Open access · CC-BY
via OpenAlex
The current status, trends, and challenges of Alzheimer’s disease and other dementias in Asia (1990–2036)
Ziyang He, Haoqin Zhang, Guishan Hu, Yinan Qiao, Can Yin, Jianqiao Li, Hong Lin, Anguo Wu, Dalian Qin, Betty Yuen Kwan Law, Guangqiang Hu, Lu Yu
Frontiers in Public Health · 2025 · ▲ 21 citations
Abstract
Background: With global aging, Alzheimer's disease (AD) and other dementias have emerged as significant health threats to the older adults, garnering considerable attention due to their impact on public health. Despite the substantial burden of dementia in Asia, targeted research remains limited. This study aims to assess the current burden, future trends, risk factors, and inequalities in Asia. Method: The GBD 2021 study was utilized to evaluate the numbers and age-standardized rates (ASRs) of prevalence, mortality, and disability-adjusted life-years (DALYs) of AD and other dementias from 1990 to 2021. Joinpoint regression analysis was performed to assess the trends during this period, while the Autoregressive Integrated Moving Average (ARIMA) model was employed to predict future trends. Additionally, the relationship between disease burden and sociodemographic index (SDI) was also analyzed. Results: In 2021, Asia experienced a 250.44% increase in prevalent cases, a 297.34% rise in mortality, and a 249.54% surge in DALYs for AD and other dementias compared to 1990. Meanwhile, the age-standardized prevalence rate, age-standardized mortality rate, and age-standardized DALY rate also exhibited varying degrees of rise from 1990 to 2021. Demographically, the disease burden was higher in women and those aged 65 and above. Regionally, the burden was highest in East Asia and relatively low in South and Central Asia. Nationally, China, India, Japan, and Indonesia reported the most cases. Over the next 15 years, the age-standardized prevalence rate in Asia is expected to peak in 2028 before declining, while the age-standardized mortality rate is anticipated to keep rising. An overall "V" shaped association was found between sociodemographic index (SDI) and the age-standardized DALY rate in Asia. Only smoking, high fasting plasma glucose (FPG), and high BMI were identified as causal risk factors within the GBD framework. Conclusion: The burden of AD and other dementias in Asia has significantly increased over the past three decades and is expected to persistently impact Asian populations, particularly in developing countries experiencing rapid demographic shifts. Women and the older adult should be a focus of attention. It is imperative to implement targeted prevention and intervention strategies, enhance chronic disease management, and control risk factors.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3389/fpubh.2025.1583339
- Canonical
- link ↗
- Fetched
- 2026-10-29 MST
Cite this
APA
He, Z., Zhang, H., Hu, G., Qiao, Y., Yin, C., Li, J., Lin, H., Wu, A., Qin, D., Law, B.Y.K., Hu, G., & Yu, L. (2025). The current status, trends, and challenges of Alzheimer’s disease and other dementias in Asia (1990–2036). <em>Frontiers in Public Health</em>. https://doi.org/10.3389/fpubh.2025.1583339
Vancouver
He Z, Zhang H, Hu G, Qiao Y, Yin C, Li J, et al. The current status, trends, and challenges of Alzheimer’s disease and other dementias in Asia (1990–2036). Frontiers in Public Health. 2025. doi:10.3389/fpubh.2025.1583339.
BibTeX
@article{ziyang2025Thecur,
title = {The current status, trends, and challenges of Alzheimer’s disease and other dementias in Asia (1990–2036)},
author = {Ziyang He and Haoqin Zhang and Guishan Hu and Yinan Qiao and Can Yin and Jianqiao Li and Hong Lin and Anguo Wu and Dalian Qin and Betty Yuen Kwan Law and Guangqiang Hu and Lu Yu},
journal = {Frontiers in Public Health},
year = {2025},
doi = {10.3389/fpubh.2025.1583339},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Diabetes, obesity & metabolism 2026
Citation only
The Burden of Alzheimer's Disease and Other Dementias Attribute to Metabolic Risks in Western Europe From 1990 to 2023.
Diabetes research and clinical practice 2026
Citation only
Global burden of chronic kidney disease due to type 2 diabetes in adults from 1990 to 2021, with exploratory projections to 2036: a systematic analysis of the Global Burden of Disease Study 2021.
IRCCS Centro San Giovanni di Dio Fatebenefratelli 2026
Open access · US-GOV
Development of Digital Solutions for the Prediction of the Biological Mechanisms of Alzheimer's Disease Through the Analysis of Risk Factors (PrevAI)
Ageing Research Reviews 2026
Open access · CC-BY
Blood-based biomarkers for Alzheimer's disease: Advances in early detection and monitoring of age-related neurodegeneration
Endocrinology and metabolism (Seoul, Korea) 2026
Citation only
Global 30-Year Trajectory and Socioeconomic Disparities of Type 2 Diabetes Mellitus in Older Adults (1990-2021).
Frontiers in aging neuroscience 2026
Citation only